DK2588078T3 - Polymersystem til tilførsel af en konserveringsfri prostaglandinbaseret ikke-viskøs opløsning - Google Patents

Polymersystem til tilførsel af en konserveringsfri prostaglandinbaseret ikke-viskøs opløsning

Info

Publication number
DK2588078T3
DK2588078T3 DK11727707.9T DK11727707T DK2588078T3 DK 2588078 T3 DK2588078 T3 DK 2588078T3 DK 11727707 T DK11727707 T DK 11727707T DK 2588078 T3 DK2588078 T3 DK 2588078T3
Authority
DK
Denmark
Prior art keywords
preservative
application
polymer system
based non
viscous solution
Prior art date
Application number
DK11727707.9T
Other languages
English (en)
Inventor
Fabrice Mercier
Original Assignee
Théa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43064334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2588078(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Théa Lab filed Critical Théa Lab
Application granted granted Critical
Publication of DK2588078T3 publication Critical patent/DK2588078T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK11727707.9T 2010-06-29 2011-06-28 Polymersystem til tilførsel af en konserveringsfri prostaglandinbaseret ikke-viskøs opløsning DK2588078T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35969910P 2010-06-29 2010-06-29
FR1055236A FR2961694B1 (fr) 2010-06-29 2010-06-29 Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
PCT/EP2011/060848 WO2012001009A1 (fr) 2010-06-29 2011-06-28 Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur

Publications (1)

Publication Number Publication Date
DK2588078T3 true DK2588078T3 (da) 2014-08-18

Family

ID=43064334

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11727707.9T DK2588078T3 (da) 2010-06-29 2011-06-28 Polymersystem til tilførsel af en konserveringsfri prostaglandinbaseret ikke-viskøs opløsning

Country Status (27)

Country Link
US (2) US20110319487A1 (da)
EP (1) EP2588078B1 (da)
JP (2) JP5657789B2 (da)
KR (1) KR101809713B1 (da)
CN (2) CN104274396B (da)
AU (1) AU2011273549B2 (da)
BR (1) BR112012033435B1 (da)
CA (1) CA2802816C (da)
CL (1) CL2012003684A1 (da)
CO (1) CO6660508A2 (da)
DK (1) DK2588078T3 (da)
EA (1) EA025026B1 (da)
ES (1) ES2486793T3 (da)
FR (1) FR2961694B1 (da)
HK (2) HK1178446A1 (da)
HR (1) HRP20140631T1 (da)
MA (1) MA34324B1 (da)
MX (1) MX2012014503A (da)
PL (1) PL2588078T3 (da)
PT (1) PT2588078E (da)
RS (1) RS53417B (da)
SG (1) SG186361A1 (da)
SI (1) SI2588078T1 (da)
SM (1) SMT201400098B (da)
TN (1) TN2012000588A1 (da)
UA (1) UA107718C2 (da)
WO (1) WO2012001009A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2929545C (en) 2009-05-01 2019-04-09 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
AU2014225305B2 (en) * 2013-03-08 2019-01-31 Polyactiva Pty Ltd Polymer conjugate for delivery of a bioactive agent
US10113033B2 (en) 2013-03-08 2018-10-30 Polyactiva Pty Ltd Polymer conjugate for delivery of a bioactive agent
CN104288092A (zh) * 2013-07-16 2015-01-21 广东东阳光药业有限公司 拉坦前列素滴眼剂
US9115109B2 (en) * 2013-08-15 2015-08-25 Chirogate International Inc. Processes and intermediates for the preparations of isomer free prostaglandins
EP3057575B1 (en) * 2013-10-15 2021-09-08 Pharmathen S.A. Preservative free pharmaceutical compositions for ophthalmic administration
GR1008330B (el) * 2013-10-17 2014-10-20 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση εχoν βελτιωμενες φυσικες ιδιοτητες και ογκο σταγονας
GR1008483B (el) * 2013-12-23 2015-05-12 Rafarm Α.Ε.Β.Ε., Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης
CN105012231A (zh) * 2014-04-30 2015-11-04 四川科伦药物研究院有限公司 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法
ES2584534B1 (es) * 2015-03-27 2017-03-13 Retinset, S.L. Formulación tópica oftálmica de bosentan
ES2747302T3 (es) * 2015-06-09 2020-03-10 Medproject Pharma Entw Und Vertriebsgesellschaft Mbh Gel oftálmico de bimatoprost aplicable en gotas
GR1009040B (el) * 2016-04-19 2017-05-19 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου
WO2018033854A1 (en) * 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
WO2018045091A1 (en) 2016-08-31 2018-03-08 Aerie Pharmaceuticals, Inc. Ophthalmic compositions
IT201600103956A1 (it) * 2016-10-17 2018-04-17 Omikron Italia S R L Formulazione oftalmica comprendente citicolina veicolata da liposomi per il trattamento del glaucoma
KR101770324B1 (ko) * 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
CA3054084A1 (en) 2017-03-14 2018-09-20 Polyactiva Pty Ltd Biodegradable drug-polymer conjugate
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate
US11207417B2 (en) 2017-03-14 2021-12-28 Polyactiva Pty Ltd Drug-polymer conjugate
CN110785162B (zh) 2017-06-22 2023-08-01 Ys生命科学株式会社 用于治疗青光眼的滴眼液组合物
LT3593788T (lt) * 2018-07-12 2021-04-12 Nicox S.A. Oftalminės kompozicijos, kurių sudėtyje yra azoto oksidą atpalaiduojantis prostamidas
WO2020028055A1 (en) * 2018-07-31 2020-02-06 ADLER, Benjamin, Aaron Ophthalmic formulations and uses thereof
US11427563B2 (en) 2018-09-14 2022-08-30 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CN110711175A (zh) * 2019-11-12 2020-01-21 南京华盖制药有限公司 一种他氟前列素滴眼剂及其制备方法
US20230263727A1 (en) * 2022-01-14 2023-08-24 Somerset Therapeutics, Llc Ophthalmologically suitable low pka buffer-containing pilocarpine compositions and related methods
US11969410B2 (en) 2022-02-09 2024-04-30 Somerset Therapeutics, Llc Low pH pilocarpine and brimonidine compound formulations and related methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10021A (en) * 1853-09-13 Screw-eastemtito- for boots and shoes
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6646001B2 (en) * 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
DE69918122T2 (de) * 1998-04-02 2005-06-16 Novartis Ag Stabilisierung pharmazeutischer zusammensetzungen durch besonderen einsatz eines antioxidans
US20030018079A1 (en) * 2000-11-13 2003-01-23 Richardson Helene Treatment
US7074827B2 (en) * 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
FR2918891B1 (fr) 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur
ES2667945T3 (es) * 2007-10-08 2018-05-16 Aurinia Pharmaceuticals Inc. Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
BRPI0818459A2 (pt) * 2007-10-16 2015-04-14 Sun Pharma Advanced Res Co Ltd Composição farmacêutica adequada para uso oftálmico.
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
FR2961694B1 (fr) 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur

Also Published As

Publication number Publication date
JP2013532159A (ja) 2013-08-15
SG186361A1 (en) 2013-01-30
JP5657789B2 (ja) 2015-01-21
SMT201400098B (it) 2014-09-08
EA025026B1 (ru) 2016-11-30
CN104274396B (zh) 2017-07-04
CA2802816A1 (fr) 2012-01-05
CN102958509B (zh) 2015-01-21
CN104274396A (zh) 2015-01-14
CO6660508A2 (es) 2013-04-30
CA2802816C (fr) 2015-05-12
EP2588078B1 (fr) 2014-05-14
EA201291307A1 (ru) 2013-05-30
US20120322871A1 (en) 2012-12-20
BR112012033435A2 (pt) 2016-11-22
HK1178446A1 (en) 2013-09-13
HK1201464A1 (en) 2015-09-04
TN2012000588A1 (fr) 2014-04-01
AU2011273549B2 (en) 2013-06-27
UA107718C2 (en) 2015-02-10
RS53417B (en) 2014-12-31
US20110319487A1 (en) 2011-12-29
FR2961694B1 (fr) 2013-01-25
ES2486793T3 (es) 2014-08-19
KR20130112728A (ko) 2013-10-14
CL2012003684A1 (es) 2013-03-08
JP5877885B2 (ja) 2016-03-08
EP2588078A1 (fr) 2013-05-08
MX2012014503A (es) 2013-01-29
FR2961694A1 (fr) 2011-12-30
HRP20140631T1 (hr) 2014-09-26
BR112012033435B1 (pt) 2022-03-29
US8637054B2 (en) 2014-01-28
JP2015038099A (ja) 2015-02-26
PT2588078E (pt) 2014-07-16
MA34324B1 (fr) 2013-06-01
KR101809713B1 (ko) 2017-12-15
SI2588078T1 (sl) 2014-09-30
PL2588078T3 (pl) 2014-09-30
WO2012001009A1 (fr) 2012-01-05
CN102958509A (zh) 2013-03-06
AU2011273549A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
DK2588078T3 (da) Polymersystem til tilførsel af en konserveringsfri prostaglandinbaseret ikke-viskøs opløsning
DK3461478T3 (da) Synkbar enhed til levering af lægemidler
DK3205405T3 (da) Væskedispenseringssystem
DK2758172T3 (da) System til udførelse af reaktioner
DK2658573T3 (da) Ekspressionssystemer
BR112014012309A2 (pt) fita de polímero reforçado com fibra assimétrica
BR112013030076A2 (pt) membranas
DK2526425T3 (da) Fremgangsmåde til diagnosticering af endometriel receptivitet
DK2619664T3 (da) Validering af tolerancen af applikationer i netværk
DK3385252T3 (da) Cannabinoidreceptormodulatorer
DK3366358T3 (da) Bæresystem til brandsikringssprinkler
DK3381490T3 (da) Sikkerhedsindretninger til injektionsindretninger
FI20115811A0 (fi) Puomisto
DK2701776T4 (da) Teknologi til samling af en dispenseringsgrænseflade
BR112013016214A2 (pt) sistemas de polímero
BR112014003740A2 (pt) variantes da celobiohidrolase
DK3240128T3 (da) System til genindvinding af ledningsrum
DK2663496T3 (da) Emballeringssystem
DK2423428T3 (da) Forseglingssystem
DK2838850T3 (da) Oprensning af titantetrachlorid
DK3002246T3 (da) System til reduktion af en krans kontravægt
BR112014002097A2 (pt) polímero
DK2756306T3 (da) Immunassay til påvisning af antibiotika
DK2901162T3 (da) Fremgangsmåde til diagnosticering af muskeldystrofi
BR112014002094A2 (pt) polímero